Search by Algolia
Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Chimerix Reports $88.4 Million Net Loss for Fiscal Year 2024, Enters Merger Agreement with Jazz Pharmaceuticals
Chimerix Reports Mixed Financial Results, Focuses on Lead Product Development